Company news

Pluri Inc. news in 2024

Pluri Inc.'s news releases, calls and decks from 2024, newest first.

View company

Pluri Collaborates with Bar-Ilan University to Advance Cancer Immunotherapy for Solid Tumors, Supported by Israel Innovation Authority

October 27, 2024

Pluri’s CDMO Selected to Manufacture Kadimastem’s Novel Cell Therapy Product Candidates

July 17, 2024

Pluri Announces €1 Million Proof of Concept Agreement to Enhance Global Sustainable Vegetable Supply

July 7, 2024

Pluri Inc. Announces 1-for-8 Reverse Share Split

March 26, 2024

Pluri Selected as CDMO by Remedy Cell for Cell-Derived Cell-Free Drug Manufacturing

March 13, 2024

Pluri Inc. Announces Appointment of Jim Roosevelt, Jr. to its Advisory Board

March 5, 2024

Step into the Future: Pluri Launches Sustainable Cell-Based Coffee as Countermeasure for Global Coffee Crisis

January 22, 2024

Pluri Launches Advanced Global Cell Therapy Contract Development and Manufacturing Organization

January 7, 2024

Decks in 2024